Posts in tag

upschedule


Supported by GSK Consumer Healthcare All modified release paracetamol products have now changed from Pharmacy Medicine (Schedule 2) to Pharmacist Only Medicine (Schedule 3). Former PSA president, John Bell discusses …

Supported by GSK Consumer Healthcare All modified release paracetamol products changed from Pharmacy Medicine (Schedule 2) to Pharmacist Only Medicine (Schedule 3). Former PSA president, John Bell discusses how this …

Supported by GSK Consumer Healthcare All modified release paracetamol products have now changed from Schedule 2 to Schedule 3 medicine. Former PSA president, John Bell discusses what this means for pharmacists …

The AMA says that recent TGA data has “vindicated” the decision to upschedule low-dose codeine Several days ago, the TGA issued a report which analysed pharmaceutical industry sales data and …

A new TGA report says the upschedule meant a “significant” drop in the amount of codeine supplied to Australians – but a Guild spokesperson says it’s early days yet A …

Debbie Rigby rounds up the latest in research news Paracetamol versus placebo for knee and hip osteoarthritis Based on high‐quality evidence this Cochrane review confirms that paracetamol provides only minimal …

The Guild has written to PainAustralia after its CEO suggested that pharmacists were responsible for increasing the price of low-dose codeine Last week the CEO of PainAustralia, Carol Bennett, said …

Tasmania is leading the way as it sets up real time monitoring of formerly-OTC codeine, pharmacy stakeholders say The island state has announced that it plans to implement Drugs and …

The Pharmacy Board has advised on handling scripts for large quantities of codeine-containing preparations In its latest communique, the Pharmacy Board has received a request for advice about how pharmacists …

Pharmacists and consumers are frustrated at the gap between supply and demand for low-dose codeine – and consumers are still confused Advantage Pharmacy CEO Steven Kastrinakis told the AJP that …

Two drugs have been causing debate this week: cannabis and, predictably, codeine A group of doctors wrote to the Medical Journal of Australia on behalf of the Royal Australasian College …

Consumers are speaking out about the lack of stock situation in pharmacies – and they’re not happy In a piece titled “Codeine ban is one painful bungle after another,” News …